Holen Sie sich die Stockscreener-App
1.34
1.47%
-0.02
Handel nachbörslich:
1.35
0.01
+0.75%
Schlusskurs vom Vortag:
$1.36
Offen:
$1.35
24-Stunden-Volumen:
44,074
Relative Volume:
0.32
Marktkapitalisierung:
$5.50M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.1344
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
-9.46%
1M Leistung:
-5.63%
6M Leistung:
-41.23%
1J Leistung:
-65.76%
1-Tages-Spanne:
$1.2998
$1.3516
1-Wochen-Bereich:
$1.2998
$1.48
52-Wochen-Spanne:
$1.215
$12.45
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Vergleichen Sie SXTP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.34 | 5.58M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
Can momentum traders help lift 60 Degrees Pharmaceuticals Inc.Weekly Trade Analysis & Safe Entry Point Identification - newser.com
Using data models to predict 60 Degrees Pharmaceuticals Inc. stock movementPortfolio Gains Summary & Daily Price Action Insights - newser.com
Why 60 Degrees Pharmaceuticals Inc. stock is popular among millennialsPortfolio Value Report & Safe Entry Trade Signal Reports - newser.com
How to integrate 60 Degrees Pharmaceuticals Inc. Equity Warrant into portfolio analysis tools2025 Institutional Moves & Verified Entry Point Signals - newser.com
How to forecast 60 Degrees Pharmaceuticals Inc. trends using time series2025 Biggest Moves & AI Forecast for Swing Trade Picks - newser.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant see short term momentumQuarterly Trade Report & Precise Trade Entry Recommendations - newser.com
News impact scoring models applied to 60 Degrees Pharmaceuticals Inc.Weekly Loss Report & Free Growth Oriented Trading Recommendations - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain operating marginsJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock affected by interest rate hikesWeekly Risk Summary & Weekly Watchlist for Consistent Profits - newser.com
Published on: 2025-11-03 05:37:50 - newser.com
How geopolitical tensions affect 60 Degrees Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Reactions & Safe Capital Growth Plans - newser.com
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock could benefit from AI revolutionBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
How to use a screener to detect 60 Degrees Pharmaceuticals Inc. Equity Warrant breakoutsOptions Play & Daily Profit Focused Stock Screening - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedTreasury Yields & Real-Time Stock Entry Alerts - newser.com
Institutional scanner results for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock attractive for hedge fundsJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock resist market sell offsTrade Analysis Report & Expert-Curated Trade Recommendations - newser.com
60 Degrees Pharmaceuticals Inc. Equity Warrant stock daily chart insightsJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com
Developing predictive dashboards with 60 Degrees Pharmaceuticals Inc. Equity Warrant data - newser.com
What’s next for 60 Degrees Pharmaceuticals Inc. Equity Warrant stock priceWall Street Watch & Daily Profit Focused Screening - newser.com
Forecasting 60 Degrees Pharmaceuticals Inc. Equity Warrant price range with options dataCPI Data & Long-Term Growth Plans - newser.com
Using AI based signals to follow 60 Degrees Pharmaceuticals Inc.Trade Volume Summary & Accurate Trade Setup Notifications - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock attractive for growth ETFs2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
Real time alert setup for 60 Degrees Pharmaceuticals Inc. performanceMarket Sentiment Report & Reliable Price Action Trade Plans - newser.com
Why analysts upgrade 60 Degrees Pharmaceuticals Inc. stockJuly 2025 Levels & Expert Verified Movement Alerts - newser.com
Has 60 Degrees Pharmaceuticals Inc. Equity Warrant formed a bullish divergenceTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Chart based analysis of 60 Degrees Pharmaceuticals Inc. Equity Warrant trendsWeekly Market Outlook & Intraday High Probability Setup Alerts - newser.com
Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investorsWeekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
How strong is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock revenue growthWeekly Trade Report & Safe Capital Growth Trade Ideas - newser.com
Predicting 60 Degrees Pharmaceuticals Inc. Equity Warrant trend using moving averagesJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
What machine learning models say about 60 Degrees Pharmaceuticals Inc.Quarterly Earnings Report & Reliable Volume Spike Trade Alerts - newser.com
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):